Literature DB >> 849992

An abnormality in steroid reductive metabolism in a hypertensive syndrome.

S Ulick, L C Ramirez, M I New.   

Abstract

Studies in a juvenile hypertensive syndrome associated with suppressed plasma renin activity and hypokalemic alkalosis failed to reveal overproduction of aldosterone or any other known steroid. There was however an abnormal increase in the fraction of unconjugated urinary steroids. Analysis of this fraction following the administration of labeled cortisol revealed that it was largely composed of dihydro metabolites reduced either at 4,5 or at C-20 and that the 4,5-dihydro fraction contained an abnormal increase in 5alpha- relative to 5beta-metabolites. There was, however, no absolute defect in the complete reduction of ring A to form tetrahydro derivatives. These findings, together with observations by Marver and Edelman that 5alpha-dihydrocortisol may be an effective mineralcorticoid, suggest the possibility of an etiologic relationship between the metabolic abnormality and the patient's hypertensive disorder.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849992     DOI: 10.1210/jcem-44-4-799

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  Apparent mineralocorticoid excess syndromes.

Authors:  M Shimojo; P M Stewart
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

2.  Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess.

Authors:  M I New; R C Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

3.  A rare cause of hypertension in childhood: Answers.

Authors:  Nuran Kucuk; Zehra Yavas Abalı; Saygın Abalı; Nur Canpolat; Gozde Yesil; Serap Turan; Abdullah Bereket; Tulay Guran
Journal:  Pediatr Nephrol       Date:  2019-09-20       Impact factor: 3.714

Review 4.  A genetic defect resulting in mild low-renin hypertension.

Authors:  R C Wilson; S Dave-Sharma; J Q Wei; V R Obeyesekere; K Li; P Ferrari; Z S Krozowski; C H Shackleton; L Bradlow; T Wiens; M I New
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

5.  Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.

Authors:  P M Stewart; J E Corrie; C H Shackleton; C R Edwards
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

Review 6.  The renin-angiotensin-aldosterone system. Past, present and future.

Authors:  P Vecsei; E Hackenthal; D Ganten
Journal:  Klin Wochenschr       Date:  1978

Review 7.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 8.  11β-hydroxysteroid dehydrogenases: A growing multi-tasking family.

Authors:  Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2021-02-17       Impact factor: 4.102

9.  Altered renal sodium handling and risk of incident hypertension: Results of the Olivetti Heart Study.

Authors:  Lanfranco D'Elia; Francesco P Cappuccio; Roberto Iacone; Ornella Russo; Ferruccio Galletti; Pasquale Strazzullo
Journal:  PLoS One       Date:  2017-02-14       Impact factor: 3.240

10.  Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism.

Authors:  Karl-Heinz Storbeck; Lina Schiffer; Elizabeth S Baranowski; Vasileios Chortis; Alessandro Prete; Lise Barnard; Lorna C Gilligan; Angela E Taylor; Jan Idkowiak; Wiebke Arlt; Cedric H L Shackleton
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.